![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
20
Norbrook Laboratories Limited Newry Ie, based in United Kingdom, is a pharmaceutical company.
One of their significant offerings is Flunixin meglumine for veterinary use, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2006-141 - Rev 00
This Chemical Type CEP, issued on March 13, 2012, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1696 associated with this CEP further emphasizes